MY199372A - Novel peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers - Google Patents

Novel peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers

Info

Publication number
MY199372A
MY199372A MYPI2018704144A MYPI2018704144A MY199372A MY 199372 A MY199372 A MY 199372A MY PI2018704144 A MYPI2018704144 A MY PI2018704144A MY PI2018704144 A MYPI2018704144 A MY PI2018704144A MY 199372 A MY199372 A MY 199372A
Authority
MY
Malaysia
Prior art keywords
peptides
targets
combination
present
cholangiocarcinoma
Prior art date
Application number
MYPI2018704144A
Inventor
Weinschenk Toni
Mahr Andrea
Wiebe Anita
Schoor Oliver
fritsche Jens
Singh Harpreet
Original Assignee
Immatics Biotechnologies Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immatics Biotechnologies Gmbh filed Critical Immatics Biotechnologies Gmbh
Priority claimed from PCT/EP2017/062334 external-priority patent/WO2017202806A1/en
Publication of MY199372A publication Critical patent/MY199372A/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T- cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
MYPI2018704144A 2016-05-25 2016-05-25 Novel peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers MY199372A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17062334 2016-05-25
PCT/EP2017/062334 WO2017202806A1 (en) 2016-05-25 2017-05-23 Novel peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers

Publications (1)

Publication Number Publication Date
MY199372A true MY199372A (en) 2023-10-24

Family

ID=94170985

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2018704144A MY199372A (en) 2016-05-25 2016-05-25 Novel peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers

Country Status (1)

Country Link
MY (1) MY199372A (en)

Similar Documents

Publication Publication Date Title
PH12018500551A1 (en) Novel peptides and combination of peptides for use in immunotherapy against various cancers
PH12018500848A1 (en) Novel peptides and combination of peptides for use in immunotherapy against cll and other cancers
PH12018500189A1 (en) Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
PH12017502261A1 (en) Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
PH12018500864A1 (en) Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
EP3875467A3 (en) Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
PH12019501377A1 (en) Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
SG10201806839PA (en) Novel peptides and combination of peptides for use in immunotherapy against various tumors
WO2017001491A3 (en) Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
PH12018500004A1 (en) Novel peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers
PH12019502308A1 (en) Peptides and combination thereof for use in the immunotherapy against cancers
MX2018011388A (en) Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers.
MX2018010875A (en) Novel peptides and combination of peptides for use in immunotherapy against various tumors.
PH12019502300A1 (en) Peptides and combination of peptides for use in immunotheraphy against leukemias and other cancers
PH12018502159A1 (en) Immunotheraphy against melanoma and other cancers
MY196837A (en) Novel peptides and combination of peptides for use in immunotherapy against various cancers
PH12017501467A1 (en) Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
PH12017502234A1 (en) Novel cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers
PH12018500665A1 (en) Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
PH12018502315A1 (en) Novel peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers
PH12018502108A1 (en) Novel peptides and combination of peptides for use in immunotherapy against aml and other cancers
PH12018501639A1 (en) Novel peptides and combination of peptides for use in immunotherapy against nhl and other cancers
MY199372A (en) Novel peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers